Results 111 to 120 of about 1,049,512 (355)

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease.

Clinical Nutrition, 2023
S. Bischoff, P. Bager, J. Escher, A. Forbes, X. Hébuterne, C. Hvas, F. Joly, S. Klek, Ž. Krznarić, J. Ockenga, S. Schneider, R. Shamir, K. Stardelova, D. Bender, N. Wierdsma, Arved Weimann   +15 more
semanticscholar   +1 more source

Evidence-based clinical practice guidelines for inflammatory bowel disease

Journal of gastroenterology, 2018
Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs.
K. Matsuoka, Taku Kobayashi, F. Ueno, T. Matsui, Fumihito Hirai, N. Inoue, J. Kato, Kenji Kobayashi, K. Kobayashi, K. Koganei, R. Kunisaki, S. Motoya, M. Nagahori, H. Nakase, F. Omata, M. Saruta, Toshiaki Watanabe, Toshiaki Tanaka, T. Kanai, Y. Noguchi, Ken­ichi Takahashi, Kenji Watanabe, T. Hibi, Yasuo Suzuki, Mamoru Watanabe, K. Sugano, T. Shimosegawa   +26 more
semanticscholar   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source

Urinary crystalloid excretion in patients with inflammatory bowel disease [PDF]

, 1970
Richard I. Breuer, E. A. Gelzayd, J. K. Kirsner   +2 more
openalex   +1 more source

Inflammatory bowel disease in the West Indies. [PDF]

, 1979
C Bartholomew, Andrew J. Butler
openalex   +3 more sources

Inflammatory Bowel Disease in Pregnancy

Gastroenterology Clinics of North America, 2011
Crohn's disease and ulcerative colitis affect women in their child-bearing years. Family planning has come to be a common discussion between the gastroenterologist and the inflammatory bowel disease (IBD) patient. Disease control prior to desired conception and throughout pregnancy is the most important thing to keep in mind when caring for the IBD ...
Dawn B. Beaulieu, Sunanda V. Kane
openaire   +4 more sources

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John, Caitlyn Dang, Nidhi Reddy, Calvin Chao, Karen J. Ho, Bin Jiang   +5 more
wiley   +1 more source

Glepaglutide‐Loaded Foam for the Induction of Mucosal Healing in the Treatment of Inflammatory Bowel Disease

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Glepaglutide (GL), a GLP‐2 analog with an extended half‐life (50 h), is currently undergoing clinical trials for patients with short bowel syndrome. GL requires subcutaneous injection, which poses challenges for potential patient compliance. To address this challenge, we loaded GL into a rectal foam formulation using CO2 as a permeation enhancer to ...
Wunan Zhang, William Van den Bossche, Hafsa Yagoubi, Espoir K Kambale, Khadija Wahni, Tanya Saxena, Léo Guilbaud, Tom G. Moreels, Joris Messens, Ana Beloqui   +9 more
wiley   +1 more source

Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease [PDF]

, 1974
Bronwyn West, R Lendrum, Michael J. Hill, G Walker   +3 more
openalex   +1 more source

Synthetic Bilirubin‐Based Nanomedicine Protects Against Renal Ischemia/Reperfusion Injury Through Antioxidant and Immune‐Modulating Activity

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
BX‐001N, a polyethylene glycol‐conjugated bilirubin 3α nanoparticle, is the first GMP‐grade, synthetic bilirubin‐based nanomedicine. It effectively attenuates acute renal injury, facilitates subacute renal recovery, and suppresses chronic fibrosis after renal ischemia/reperfusion injury via anti‐oxidant and immune‐modulating activity.
Ji‐Jing Yan, Hyunjin Kim, Bomin Kim, Honglin Piao, Joon Young Jang, Tae Kyeom Kang, Wook‐Bin Lee, Dohyeon Kim, Seunghyun Jo, Duckhyang Shin, Sharif MD Abuzar, Myung L. Kim, Jaeseok Yang, Sangyong Jon   +13 more
wiley   +1 more source